跳至主要内容
临床试验/CTRI/2025/03/081541
CTRI/2025/03/081541尚未招募Phase 3 4

C-Safe: Optimizing maternal and perinatal outcomes through safe and appropriate caesarean sections in low-and middle-income countries (LMIC)EC.Ref No. 47_2023

University of Birmingham5 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2025年3月31日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
入组人数
4,000
试验地点
5
主要终点
Our main outcomes include the following:Caesarean section rate per month, Assisted vaginal birth rate per month, Vaginal birth rate (not including assisted vaginal births) per month, Rates of mode of birth in Robsons groups (1-4) per month, Indications for caesarean sections per month, Use of C-Safe checklists and delivery of the C-Safe packages (C-Op and C-Non) per month

研究概览

简要总结

C-Safe aims to develop, implement, and evaluate a multi-faceted intervention (C-Safe) targeting healthcare professionals, pregnant women, families, communities and health systems to reduce maternal and perinatal mortality and morbidity following caesarean section (CS) in Iow- and middle-income countries (LMIC).

 It is a programme with four work packages.

-         package 1 and 2 map the evidence and prioritize components of the intervention and outcome measures.

-         package 3 will co-develop and refine the intervention in a field testing phase

-         package 4 will test the intervention (stepped wedge cluster randomised controlled trial with surveys and qualitative research).

 This registration and these methods relate specifically to packages 3 and 4.

 Given the complex challenges that affect trial design and successful implementation in the C-Safe intervention, a field-testing phase will be conducted ahead of the cluster trial. The field-testing phase will use mixed-methods to understand how birth is currently managed in the study settings, as a basis for tailoring and adapting the implementation of the intervention.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Subjects include healthcare professionals and managers in maternity wards of the selected facilities, as well as women who have given birth in the previous month.
  • Cluster: Health facilities are eligible for inclusion if:
  • Urban or peri-urban public facility
  • Secondary or tertiary-level
  • Providing comprehensive emergency obstetric care (50) over 12 months (see Box 1)
  • Minimum of 4,000 births/ year.

排除标准

  • Sites used in the field-testing phase will not be eligible to participate in the stepped wedged randomized trial.
  • We will exclude sites if they are not providing Comprehensive Emergency Obstetric and Newborn Care.
  • We will also exclude sites if they were or are, part of another intervention trial, or if any components of the C-Safe interventional package were previously tested on them.
  • Co-enrolment with sites with existing related studies will be discouraged.

结局指标

主要结局

Our main outcomes include the following:Caesarean section rate per month, Assisted vaginal birth rate per month, Vaginal birth rate (not including assisted vaginal births) per month, Rates of mode of birth in Robsons groups (1-4) per month, Indications for caesarean sections per month, Use of C-Safe checklists and delivery of the C-Safe packages (C-Op and C-Non) per month

时间窗: 3, 6 ,9 months

次要结局

  • secondary outcomes are those on implementation, acceptability, equity and clinical outcomes(implementation- 3 months, Acceptability - baseline, 3,6 and 12 months,)

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Ms Inderjeet Kaur

Fernandez Foundation

研究点 (5)

Loading locations...

相似试验